Hyperway Pharm

company

About

Hyperway Pharm IS A Pharmaceutical research and development production enterprise

  • 11 - 50

Details

Last Funding Type
Series A
Industries
Health Care,Pharmaceutical
Founded date
Jan 1, 2019
Number Of Employee
11 - 50
Operating Status
Active

Hyperway Pharm is a pharmaceutical R&D and production enterprise with R&D as the core driving force. It adheres to the philosophy of “Hai Na Baichuan, Bocai, Changzhi, Good People, and Great Deeds”, and is committed to building a world-leading research and development platform for small molecule innovative drugs and high-end APIs. Research and development platform for research and development platforms and high-tech barriers. Its core founding team is a special high-end talent in Chengdu, Sichuan Province, and has many Fortune 500 companies such as Bayer, Johnson & Johnson, Sanofi and Merck, as well as “Kingming Kant”. Work experience of domestic well-known pharmaceutical companies such as “Hengrui”, “Yangzijiang”, “Hai Cisco”, “Smart Chemical” and “Bite Pharmaceutical”, with rich experience in international and domestic drug development and management, and led the team. It has successively developed a number of world-class innovative drugs (which have entered clinical trials) and a number of high-end high-end generic drugs

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
Hyperway Pharm has raised a total of — in funding over 2 rounds. Their latest funding was raised on Apr 14, 2021 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 14, 2021 Series A 2 Huaige Capital Detail

Investors

Number of Lead Investors
Number of Investors
1
2
Hyperway Pharm is funded by 2 investors. Huaige Capital and Sichuan Yuanshi Fund are the most recent investors.
Investor Name Lead Investor Funding Round
Huaige Capital Yes Series A
Sichuan Yuanshi Fund Series A